Analysts Set agilon health, inc. (NYSE:AGL) Target Price at $4.03

agilon health, inc. (NYSE:AGL) has received an average recommendation of “Hold” from the eighteen ratings firms that are covering the company, MarketBeat.com reports. Two analysts have rated the stock with a sell recommendation, fourteen have issued a hold recommendation and two have assigned a buy recommendation to the company. The average twelve-month target price among brokers that have issued a report on the stock in the last year is $4.03.

AGL has been the subject of several analyst reports. Sanford C. Bernstein raised their target price on agilon health from $2.50 to $3.15 and gave the stock a “market perform” rating in a research note on Wednesday, January 15th. William Blair downgraded agilon health from an “outperform” rating to a “market perform” rating in a research note on Friday, November 8th. Royal Bank of Canada restated an “outperform” rating and issued a $3.00 target price on shares of agilon health in a research note on Tuesday, November 19th. Needham & Company LLC started coverage on agilon health in a research note on Friday, January 10th. They issued a “hold” rating for the company. Finally, Citigroup raised agilon health from a “sell” rating to a “neutral” rating and raised their price target for the company from $1.75 to $2.25 in a report on Friday, January 10th.

agilon health Stock Up 3.6 %

AGL stock opened at $3.56 on Thursday. agilon health has a fifty-two week low of $1.50 and a fifty-two week high of $7.73. The stock has a fifty day moving average of $2.77 and a 200-day moving average of $3.12. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.29 and a current ratio of 1.29. The company has a market capitalization of $1.47 billion, a price-to-earnings ratio of -3.79 and a beta of 0.67.

Insiders Place Their Bets

In related news, Director Karen Mcloughlin purchased 25,000 shares of the firm’s stock in a transaction on Friday, December 13th. The shares were acquired at an average cost of $2.20 per share, with a total value of $55,000.00. Following the purchase, the director now directly owns 73,166 shares of the company’s stock, valued at approximately $160,965.20. This trade represents a 51.90 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Diana Mckenzie purchased 12,500 shares of the firm’s stock in a transaction on Monday, November 25th. The stock was bought at an average cost of $2.28 per share, for a total transaction of $28,500.00. Following the completion of the purchase, the director now directly owns 51,319 shares in the company, valued at approximately $117,007.32. This trade represents a 32.20 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have purchased 90,000 shares of company stock valued at $198,100 in the last ninety days. Company insiders own 3.20% of the company’s stock.

Institutional Investors Weigh In On agilon health

A number of large investors have recently made changes to their positions in the business. Captrust Financial Advisors grew its position in shares of agilon health by 10.9% in the 4th quarter. Captrust Financial Advisors now owns 35,485 shares of the company’s stock worth $67,000 after buying an additional 3,494 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its position in shares of agilon health by 2.5% in the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 206,991 shares of the company’s stock worth $393,000 after buying an additional 5,107 shares during the last quarter. MetLife Investment Management LLC grew its position in shares of agilon health by 4.0% in the 4th quarter. MetLife Investment Management LLC now owns 174,551 shares of the company’s stock worth $332,000 after buying an additional 6,762 shares during the last quarter. Symphony Financial Services Inc. grew its position in shares of agilon health by 44.3% in the 4th quarter. Symphony Financial Services Inc. now owns 23,000 shares of the company’s stock worth $44,000 after buying an additional 7,058 shares during the last quarter. Finally, Point72 Asia Singapore Pte. Ltd. bought a new stake in shares of agilon health in the 3rd quarter worth approximately $28,000.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.